Increased glutamate transporter (GLT-1) immunoreactivity in the rat striatum after repeated intermittent administration of methamphetamine

Annals of the New York Academy of Sciences

Volumn 801, Issue , 1996, Pages 310-314

  Nishino, N ^a   Shirai, B Y ^a   Kajimoto, Y ^a   Kitamura, N ^a   Yamamoto, H ^a   Yang, C Q ^a   Shirakawa, O ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; METHAMPHETAMINE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; HEAD MOVEMENT; IMMUNOBLOTTING; IMMUNOREACTIVITY; MACROGLIA; MALE; NERVE ENDING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; STEREOTYPY;

ANIMALIA;

EID: 0030474191     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17451.x     Document Type: Conference Paper

References (16)

1. CARLSSON, M. & A. CARLSSON. 1990. Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease. Trends Neurol. Sci. 13: 272-276.
2. DEUTSCH, S. I., J. MASTROPAOLO, B. L. SCHWARTZ, R. B. ROSSE & J. M. MORIHISA. 1989. A "glutamate hypothesis" of schizophrenia: rationale for pharmacotherapy with glycine. Clin. Neuropharmacol. 12: 1-13.
3. ROBINSON, T. E. & J. B. BECKER. 1986. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evauation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198.
4. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA 89: 10955-10959.
5. PINES, P., N. C. DANBOLT, M. BJORAS, Y. ZHANG, A. BENDAHAN, L. EIDE, H. KOEPSELL, J. STROM-MATHISEN, E. SEEBERG & B. I. KANNER. 1992. Cloning and expression of a rat brain L-glutamate transporter. Nature 360: 464-467.
6. KANAI, Y. & M. A. HEDIGER. 1992. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360: 467-471.
7. FAIRMAN, W. A., R. J. VANDENBERG, J. L. ARRIZA, M. P. KAVANAUGH & S. G. AMARA. 1995. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375: 599-603.
8. UJIKE, H., K. AKIYAMA & S. OTSUKI. 1990. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology 102: 459-464.
9. ROTHSTEIN, J. D., L. MARTIN, A. I. LEVEY, M. DYKES-HOBERG, L. JIN, D. WU, N. NASH & R. W. KUNCL. 1994. Localization of neuronal and glial glutamate transporters. Neuron 13: 713-725.
10. SONSALLA, P. K., W. J. NICKLAS & R. E. HEIKKILA. 1989. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398-400.
11. ABEKAWA, T., T. OHMORI & T. KOYAMA. 1994. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643: 279-281.
12. DAHL, D. & A. BIGNAMI. 1973. Glial fibrillary acidic protein from normal human brain, purification and properties. Brain Res. 57: 343-360.
13. KERKERIAN, L., N. DUSTICIER & A. NIEOULLON. 1987. Modulatory effects of dopamine on high-affinity glutamate uptake in the rat striatum. J. Neurochem. 48: 1301-1306.
14. WOLF, M. E., F. J. WHITE, R. NASSAR, R. J. BROODERSON & M. R. KHANSA. 1991. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 258: 882-890.
15. KARLER, R., L. D. CALDER, L. H. THAI & J. B. BEDINGFIELD. 1994. A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res. 658: 8-14.
16. ROTHSTEIN, J. D. & B. TABAKOFF. 1985. Glial neuronal glutamate transport following glutamate synthetase inhibition. Biochem. Pharmacol. 34: 73-79.